Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
 
Users online: 1048  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page


 
Table of Contents 
CORRESPONDENCE
Year : 2014  |  Volume : 59  |  Issue : 5  |  Page : 516-517
Authors' Reply


1 Department of Dermatology and Venereology, Government Medical College, Thrissur, Kerala, India
2 Department of Psychiatry, Government Medical College, Thrissur, Kerala, India

Date of Web Publication1-Sep-2014

Correspondence Address:
N Asokan
Department of Dermatology and Venereology, Government Medical College, Thrissur, Kerala
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions



How to cite this article:
Asokan N, Prathap P, Rejani P P. Authors' Reply. Indian J Dermatol 2014;59:516-7

How to cite this URL:
Asokan N, Prathap P, Rejani P P. Authors' Reply. Indian J Dermatol [serial online] 2014 [cited 2019 Jun 26];59:516-7. Available from: http://www.e-ijd.org/text.asp?2014/59/5/516/139915


Sir,

We thank Mr. Ho and Mr. Antrum for the interest shown in our article and the in-depth analysis of it. The queries raised by them give us an opportunity to explain more about the methods and conclusions of our study. [1]

  1. It is true that Psoriasis Area and Severity Index (PASI) was not normally distributed in our study population, but skewed to the left; similar to the observations in most case series. Cut off value of PASI to define severity of psoriasis was suggested as '12 or above' in a previous study [2] and 'above 10' in another. [3] We considered that categorizing the study population into less severe and more severe using the third quartile will be better than depending on any pre-determined cut off value. This would make the definition of severity more relevant to our study population and therefore less arbitrary. Patients in the highest quarter of severity could unarguably be considered as having more severe disease. It may be noted that the cut off value we obtained (13.88) was close to the values suggested earlier. It may also be noted that median and quartiles are less sensitive to extreme values when compared with mean and hence are more appropriate to analyze skewed data.
  2. Though smoking and alcohol have been found to be confounding factors for several outcome measures, including in various studies on psoriasis; our data showed that alcohol by itself was not affecting severity, except when combined with smoking. Separate analysis for each group-smokers only, alcohol users only and those who smoked and consumed alcohol-showed that Odd's ratio (OR) for severity of those who had both habits was significant at 1.77 (CI = 1.06, 2.96); but that was mostly contributed by 'smoking only group' with OR = 1.69 (CI = 1.03, 2.77), rather than by 'alcohol use alone group' which was not significant with OR = 1.13 (CI = 0.69, 1.85). So alcohol use was not considered a confounding factor in our study.
  3. Any possible impact on severity of psoriasis due to substance use is a result of the biological changes induced by it. So, we thought that it would be more appropriate to use instruments which would reflect such changes more effectively, rather than just quantitative measures as provided by cigarette pack years or alcohol units. This indeed was a deliberately introduced novelty in the design of this study. We agree with Mr. Ho and Mr. Antrum that it would be of interest to study the effects of smoking cessation on severity of psoriasis and look forward to studies designed for that purpose in future.


 
   References Top

1.Ho JK, Antrum JH. Comment on: Asokan N, et al. "Severity of psoriasis among adult males is associated with smoking, not with alcohol use. Indian J Dermatol 2014;59:5.  Back to cited text no. 1
  Medknow Journal  
2.Feldman SR. A quantitative definition of severe psoriasis for use in clinical trials. J Dermatolog Treat 2004;15:27-9.  Back to cited text no. 2
    
3.Finlay AY. Current severe psoriasis and the rule of tens. Br J Dermatol 2005;152:861-7.  Back to cited text no. 3
    




 

Top
Print this article  Email this article
 
 
  Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (375 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed726    
    Printed12    
    Emailed0    
    PDF Downloaded38    
    Comments [Add]    

Recommend this journal